The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...

Researchers at Penn Medicine have developed an mRNA vaccine that could potentially cure allergies by stopping allergens from ...

Two new analyses, one from France and one from China, suggest that seasonal influenza vaccination provided moderate protection during the early months of the 2025–26 flu season, despite the rapid ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move beyond one-time attacks and short-term memory to become a long-term immunity ...

The government has finalised a draft national policy to promote local vaccine manufacturing, offering 10-year financial ...

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...